                                                                                                                                                                       0             1
                                The CHMP started the official Rolling (RR) process based on preliminary \nresults from the NIAID-sponsored study CO-US-540-5776 (ACTT1). 30 April 2020
The applicant submitted documentation as part of a rolling review on the \nquality, non-clinical and clinical data to support the marketing authorization \napplication.    1 May 2020
                                                                                                                  The Rapporteurs circulated Joint Assessment reports on   11 May 2020
                                                                                                          The Rapporteurs circulated updated Joint Assessment reports on   14 May 2020
                                                                                                                                                                                                             0            1
Extraordinary CHMP was held on and an interim Opinion on the RR was \nadopted by the EMEA Task Force (ETF)/CHMP (inviting the applicant to \nsubmit an application for conditional marketing authorisation) on  15 May 2020
                                                                                                                                                                    The application was received by the EMA on  5 June 2020
                                                                                                                                                                                      The procedure started on  8 June 2020
                                                                                                                             The Rapporteurs’ first Assessment Reports was circulated to all CHMP \nmembers on 12 June 2020
                                                                                                                          Updated Rapporteurs’ Joint Assessment Report was circulated to all CHMP \nmembers on 16 June 2020
                                                                                                 The PRAC agreed on the PRAC Assessment Overview and Advice to CHMP \nduring the Extraordinary PRAC meeting on 18 June 2020
                                                                                                                                                                                Extraordinary CHMP was held on 19 June 2020
                                                                                                                     The Rapporteurs updated Joint Assessment reports were circulated to all \nCHMP members on 19 June 2020
       The CHMP, in the light of the overall data submitted and the scientific \ndiscussion within the Committee, issued a positive opinion for granting a \nconditional marketing authorisation to Veklury on 25 June 2020